Solta Medical: 5 Things No One Tells You About Fraxel, Thermage & TCO

I've been handling contracts for aesthetic laser equipment for about six years now. In that time, I've made some costly mistakes—like the time I greenlit a Fraxel service package without fully understanding the consumables cost. That error hit us for over $3,200 in unexpected spending in Q4 2023, and I documented every bit of it to make sure our team never repeated it.

This article is my attempt to share what I've learned about Solta Medical's portfolio—Thermage, Fraxel, Clear & Brilliant, and IPL systems—especially for other procurement folks or clinic owners who are evaluating these devices. I'll answer the questions I wish someone had answered for me.

What exactly is Solta Medical?

Solta Medical is a subsidiary of Bausch Health Companies, and they're basically the parent company behind some of the most recognizable names in aesthetic dermatology: Thermage (RF skin tightening), Fraxel (fractional laser resurfacing), Clear & Brilliant (gentle fractional laser), and IPL (intense pulsed light) systems.

They don't sell directly to consumers, by the way. If you're a patient, you find their devices in dermatology clinics and medispas. As a provider, you're buying from Solta through their distribution network. That's the B2B dynamic you need to understand.

Take this with a grain of salt—this was accurate as of mid-2024. Bausch's corporate structure shifts occasionally, so verify current organizational details if you're doing due diligence.

Is Fraxel good for acne scars?

Short answer: yes, it's one of the most studied devices for this. But I'm not 100% sure why it works as well as it does for some patients versus others. My best guess is it comes down to scar type and skin tone, but that's outside my procurement lane.

What I can tell you is that Fraxel has a mountain of clinical data supporting its use for acne scarring. The device uses fractional laser technology, which creates micro-injuries in the skin to stimulate collagen remodeling. Per FTC guidelines on advertising substantiation, you can't make claims about outcomes without evidence, and Fraxel has that evidence.

For a practice evaluating whether to add Fraxel for this indication, the question isn't if it works. It's whether the demand exists in your patient base to justify the device investment—which brings me to my next point.

How do I evaluate Solta Medical stock or investment potential?

I get this question a lot. Solta isn't a standalone publicly traded company. It sits under Bausch Health Companies (NYSE: BHC). So when people ask about "Solta Medical stock," they're usually confused.

Honestly, I've never fully understood the financial engineering of how Bausch segments its reporting. If someone has insight, I'd love to hear it. What I do know is that Solta's performance is tied to Bausch's broader financial health, which has been rocky post the Valeant-era debt load.

The most frustrating part of evaluating these devices as an investment for a clinic: the device price is only the beginning. You need to think in terms of total cost of ownership (TCO), not just the hardware cost.

What's the real cost of a Thermage or Fraxel system? (The TCO breakdown)

This is where I see clinics make mistakes. The $50,000 quote for a Thermage system might look reasonable, but the TCO tells a different story.

"The $50,000 quote turned into $78,000 in year one after we added tip replacements, service contracts, training fees, and marketing materials. The 'cheaper' competitor we passed on actually had a lower TCO when we ran the numbers retrospectively."

Here's what I now calculate before comparing any Solta vendor quote:

• Base device price — Negotiable, but don't expect huge discounts on flagship brands like Thermage or Fraxel.
• Consumables and tips — Thermage uses single-use tips. Fraxel has treatment tips that wear out. These are recurring costs that can add up to $100-$400 per treatment depending on the protocol.
• Service contract — Usually 10-15% of device cost annually. Skip it at your own risk; laser repair is not cheap.
• Training and certification — Solta requires provider training. Factor in travel, time, and certification fees.
• Marketing support — Solta provides some co-marketing, but you'll still need local advertising to drive patient volume.
• Financing costs — If you're leasing or financing the device, the interest adds up.

The surprise wasn't the device price. It was how much hidden value came with the "expensive" option—support, revisions, and consumables management. Never expected the budget vendor to outperform the premium one on TCO. Turns out their process was actually more refined for our specific needs.

How do I find a provider who uses genuine Solta devices?

This is a patient question, but as a procurement professional, it affects how you position your services. Patients are increasingly savvy about device authenticity. Solta runs a "Find a Provider" tool on their website, which is a good starting point.

I've learned this in 2020: the landscape may have evolved, especially with new technology options and counterfeit devices in some markets. Encourage your patients to verify that a clinic is an authorized Solta provider. This protects your investment and your reputation.

What's the difference between Fraxel and Clear & Brilliant?

This comes up constantly. They're both fractional lasers from Solta, but designed for different patient needs and treatment depths.

• Fraxel: Deeper penetration. Used for acne scars, surgical scars, significant photoaging, and melasma. More downtime (3-7 days of redness/peeling). Higher per-treatment cost.
• Clear & Brilliant: Gentler, more superficial. Used for maintenance, prevention of aging, improving skin texture and tone. Minimal downtime (a day of pinkness). Lower per-treatment cost.

Think of it this way: Fraxel is the renovation, Clear & Brilliant is the upkeep. A practice should ideally offer both to capture the full patient lifecycle—maintenance clients today become renovation clients tomorrow.

I'm not sure why some practices try to position them as competing options rather than complementary. My best guess is it's a sales training gap. If you're investing in Solta, invest in proper staff education to avoid this confusion.

Is Fraxel good for acne scars? (Yes, but plan for the revenue cycle)

I already said yes, but the procurement angle matters. Fraxel for acne scars requires multiple sessions (usually 3-5), which means multiple patient visits and revenue opportunities. However, it also means multiple consumable tips per patient. Factor that into your pricing model.

Don't hold me to this, but the consumables cost per Fraxel session is roughly $150-$250 depending on the tip type and whether you're doing a full face or a smaller area. If you're charging $800 per session, the margin holds up well. But if you're discounting aggressively (which never_say: "We are the cheapest"), the margin evaporates fast.

The most frustrating part of device procurement: you can't return the consumables if patient volume doesn't materialize. After the third time we over-ordered tips for a new device, I was ready to give up on forecasting entirely. What finally helped was building in a 3-month ramp-up buffer rather than ordering for full capacity from day one.

This pricing was accurate as of Q4 2024. The market changes fast, so verify current rates before budgeting. Solta may adjust consumable pricing annually.

Final thought (not a conclusion, just a reality check)

If you're evaluating Solta Medical devices—Thermage, Fraxel, Clear & Brilliant, or their IPL systems—you're looking at premium brands with proven clinical data. But premium doesn't mean "best for every practice." Evaluate based on TCO, not brand recognition. I've made that mistake so you don't have to.

That $3,200 error in 2023? It came from ordering Fraxel tips for a protocol we didn't actually use. Check your protocol first, order second. It's that simple—and I had to learn it the hard way.